Literature DB >> 6319746

Nucleotide sequence of AKV murine leukemia virus.

W Herr.   

Abstract

AKV is an endogenous, ecotropic murine leukemia virus that serves as one of the parents of the recombinant; oncogenic mink cell focus-forming viruses that arise in preleukemic AKR mice. I report the 8,374-nucleotide-long sequence of AKV, as determined from the infectious molecular clone AKR-623. The 5'-leader sequence of AKV extends to nucleotide 639, after which lies a long open reading frame encoding the gag and pol gene products. The reading frame is interrupted by a single amber codon separating the gag and pol genes. The pol gene overlaps the env gene within the 3' region of the AKV genome. The nucleotide sequence of the 5' region of AKV reveals the following features. (i) The 5'-leader sequence lacks any AUG codon to initiate translation of gPr80gag, suggesting that gPr80gag is not required for the replication of AKV. (ii) A short portion of the leader region diverges in sequence from the closely related Moloney murine leukemia virus and appears to be related to a sequence highly repeated in eucaryotic genomes. (iii) As in Moloney murine leukemia virus, there is a potential RNA secondary structure flanking the amber codon that separates the gag and pol genes. This structure might function as a regulatory protein binding site that controls the relative levels of synthesis of the gag and pol precursors. The nucleotide sequence of the 3' region of AKV is compared with sequences reported previously from both infectious and noninfectious molecular clones of AKV.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319746      PMCID: PMC255488     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Acceleration of leukemogenesis in AKR mice by grafts, cell suspensions, and cell-free centrifugates of thymuses from preleukemic AKR donors.

Authors:  Y Nishizuka; K Nakakuki
Journal:  Int J Cancer       Date:  1968-03-15       Impact factor: 7.396

Review 2.  On the natural history of the murine leukemias: presidential address.

Authors:  H S Kaplan
Journal:  Cancer Res       Date:  1967-08       Impact factor: 12.701

3.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

4.  Somatically acquired recombinant murine leukemia proviruses in thymic leukemias of AKR/J mice.

Authors:  W Herr; W Gilbert
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

5.  Nucleotide sequence of the 3' end of MCF 247 murine leukemia virus.

Authors:  M Kelly; C A Holland; M L Lung; S K Chattopadhyay; D R Lowy; N H Hopkins
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

6.  Isolation and mapping of cDNA hybridization probes specific for ecotropic and nonecotropic murine leukemia proviruses.

Authors:  W Herr; D Schwartz; W Gilbert
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

7.  A new class of murine leukemia virus associated with development of spontaneous lymphomas.

Authors:  J W Hartley; N K Wolford; L J Old; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  A core polyprotein of murine leukemia virus on the surface of mouse leukemia cells.

Authors:  J S Tung; T Yoshiki; E Fleissner
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

9.  Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice.

Authors:  W P Rowe
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

10.  Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice.

Authors:  W P Rowe; T Pincus
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

View more
  112 in total

1.  Molecular and phylogenetic analysis of SRS 19-6 murine leukemia virus.

Authors:  L M Bundy; H Fan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Genome structure and thymic expression of an endogenous retrovirus in zebrafish.

Authors:  Ching-Hung Shen; Lisa A Steiner
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.

Authors:  K M Felsenstein; S P Goff
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.

Authors:  A Engelman; R Craigie
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation.

Authors:  E C Jørgensen; F S Pedersen; P Jørgensen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Direct determination of the point mutation rate of a murine retrovirus.

Authors:  R J Monk; F G Malik; D Stokesberry; L H Evans
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  Retroviral capsid determinants of Fv1 NB and NR tropism.

Authors:  Anthony Stevens; Michael Bock; Scott Ellis; Paul LeTissier; Kate N Bishop; Melvyn W Yap; Willie Taylor; Jonathan P Stoye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Integration of the BALB/c ecotropic provirus into the colony-stimulating factor-1 growth factor locus in a myc retrovirus-induced murine monocyte tumor.

Authors:  W R Baumbach; E M Colston; M D Cole
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.

Authors:  A C Massey; S C Lawrenz-Smith; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  A replication-competent, endogenous retrovirus from an aged DBA/2 mouse contains the complete env from Emv-3 and a novel gag partially related to AKT-8.

Authors:  T Bartman; D M Murasko; K J Blank
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.